Watch SBRA. Know when insiders buy.
One email the day a filing lands. Free.
SBRA
Sabra Health Care REIT, Inc.
20.79
−0.02 −0.10%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · insiders 25, shorts 48
Insiders, 90 days
−$4.2M
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $5.3BP/E 80.0DIV YIELD 5.77%FCF YIELD —REV TTM $859.6M +17.3%NET INCOME $65.4M −64.1%NET DEBT $2.4B52W 17.23 – 22.39SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q 2026 · Jun 30 | $235.9M | +24.7% | — | — | −$25.2M | −138.5% | -0.10 | $85.8M | — | — | Aug 3 |
| Q 2026 · Mar 31 | $221.8M | +20.8% | — | — | $40.9M | +1.4% | 0.16 | $98.4M | — | — | Aug 3 |
| Q 2025 · Dec 31derived | $211.9M | +16.2% | — | — | $27.2M | −41.7% | 0.11 | $87.4M | — | — | Feb 12 |
| Q 2025 · Sep 30 | $190M | +6.8% | — | — | $22.5M | −24.3% | 0.09 | $100M | — | — | Nov 5 |
| Q 2025 · Jun 30 | $189.2M | +7.4% | — | — | $65.5M | +173.4% | 0.27 | $81M | — | — | Aug 3 |
| Q 2025 · Mar 31 | $183.5M | +10.1% | — | — | $40.3M | +53.5% | 0.17 | $80.3M | — | — | Apr 29 |
| Q 2024 · Dec 31derived | $182.3M | +11.6% | — | — | $46.7M | +172.2% | 0.20 | $80M | — | — | Feb 12 |
| Q 2024 · Sep 30 | $178M | +10.1% | — | — | $29.8M | — | 0.13 | $97.7M | — | — | Nov 5 |
| Q 2024 · Jun 30 | $176.1M | — | — | — | $24M | — | 0.10 | $80.1M | — | — | Aug 4 |
| Q 2024 · Mar 31 | $166.7M | — | — | — | $26.3M | — | 0.11 | $52.8M | — | — | May 5 |
| Q 2023 · Dec 31derived | $163.4M | — | — | — | $17.2M | — | 0.07 | $78.7M | — | — | Feb 12 |
| Q 2023 · Sep 30 | $161.6M | — | — | — | −$15.1M | — | -0.07 | $83.2M | — | — | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $774.6M | — | — | $155.6M | 20.1% | 0.64 | $348.6M | — | — | — | $289.5M |
| FY2024 · to Dec 31 | $703.2M | — | — | $126.7M | 18.0% | 0.54 | $310.5M | — | — | — | $280.1M |
| FY2023 · to Dec 31 | $647.5M | — | — | $13.8M | 2.1% | 0.06 | $300.6M | — | — | — | $277.4M |
| FY2022 · to Dec 31 | $624.8M | — | — | −$77.6M | -12.4% | -0.34 | $315.7M | — | — | — | $277.2M |
| FY2021 · to Dec 31 | $569.5M | — | — | −$113.3M | -19.9% | -0.52 | $356.4M | — | — | — | $262.9M |
| FY2020 · to Dec 31 | $598.6M | — | — | $138.4M | 23.1% | 0.67 | $354.9M | — | — | — | $278.3M |
Every number comes from Sabra Health Care REIT, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.